Literature DB >> 21102531

Pediatric oncology: G-CSF counteracts chemotherapy toxicity in neuroblastoma.

Heidi Russell, Jason M Shohet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21102531     DOI： 10.1038/nrclinonc.2010.195

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.

Authors:  Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Shakeel Modak; Karima Yataghene; Nai-Kong V Cheung
Journal:  J Clin Oncol       Date:  2004-12-15       Impact factor: 44.544

2.  Targeted molecular therapy for neuroblastoma: the ARF/MDM2/p53 axis.

Authors:  Eugene Kim; Jason Shohet
Journal:  J Natl Cancer Inst       Date:  2009-11-10       Impact factor: 13.506

3.  Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.

Authors:  Dominique Valteau-Couanet; Jean Michon; Andrée Boneu; Chantal Rodary; Yves Perel; Christophe Bergeron; Hervé Rubie; Carole Coze; Dominique Plantaz; Frédéric Bernard; Pascal Chastagner; Jeannine Bouzy; Olivier Hartmann
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

4.  Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.

Authors:  Ruth Ladenstein; Dominique Valteau-Couanet; Penelope Brock; Isaac Yaniv; Victoria Castel; Geneviève Laureys; Josef Malis; Vassilios Papadakis; Ana Lacerda; Ellen Ruud; Per Kogner; Miklos Garami; Walentyna Balwierz; Henrik Schroeder; Maja Beck-Popovic; Günter Schreier; David Machin; Ulrike Pötschger; Andrew Pearson
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

5.  Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Authors:  K K Matthay; J G Villablanca; R C Seeger; D O Stram; R E Harris; N K Ramsay; P Swift; H Shimada; C T Black; G M Brodeur; R B Gerbing; C P Reynolds
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

6.  Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.

Authors:  Loen M Hansford; Wayne D Thomas; Joanna M Keating; Catherine A Burkhart; Anne E Peaston; Murray D Norris; Michelle Haber; Patricia J Armati; William A Weiss; Glenn M Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

7.  The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Authors:  Susan L Cohn; Andrew D J Pearson; Wendy B London; Tom Monclair; Peter F Ambros; Garrett M Brodeur; Andreas Faldum; Barbara Hero; Tomoko Iehara; David Machin; Veronique Mosseri; Thorsten Simon; Alberto Garaventa; Victoria Castel; Katherine K Matthay
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

8.  High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.

Authors:  Andrew D J Pearson; C Ross Pinkerton; Ian J Lewis; John Imeson; Caroline Ellershaw; David Machin
Journal:  Lancet Oncol       Date:  2008-03       Impact factor: 41.316

9.  Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.

Authors:  Liping Song; Shahab Asgharzadeh; Jill Salo; Kelly Engell; Hong-wei Wu; Richard Sposto; Tasnim Ara; Ayaka M Silverman; Yves A DeClerck; Robert C Seeger; Leonid S Metelitsa
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

10.  Long-term follow-up care for pediatric cancer survivors.

Authors: 
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124
  10 in total
  4 in total

1.  G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Authors:  Saurabh Agarwal; Anna Lakoma; Zaowen Chen; John Hicks; Leonid S Metelitsa; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2015-04-23       Impact factor: 12.701

2.  Surgical wound healing using hemostatic gauze scaffold loaded with nanoparticles containing sustained-release granulocyte colony-stimulating factor.

Authors:  Weien Yuan; Zhenguo Liu
Journal:  Int J Nanomedicine       Date:  2011-12-02

Review 3.  Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.

Authors:  Irina V Kholodenko; Daniel V Kalinovsky; Igor I Doronin; Sergey M Deyev; Roman V Kholodenko
Journal:  J Immunol Res       Date:  2018-07-11       Impact factor: 4.818

4.  Sustained-release G-CSF microspheres using a novel solid-in-oil-in-oil-in-water emulsion method.

Authors:  Guang Liu; Xiaoyun Hong; Mier Jiang; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2012-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.